NatureCell Co

NatureCell Co Financial Leverage

The Financial Leverage (Equity Multiplier) of NatureCell Co (007390.KQ) as of Oct 31, 2026 is 1.19. In the previous year, Financial Leverage (Equity Multiplier) was 1.11 — a change of 6.42% (higher).

Financial Leverage

1.19

YoY

6.42%

Last updated:

Financial Leverage (Equity Multiplier) of NatureCell Co is 2025 1.19 . Financial Leverage (Equity Multiplier) of NatureCell Co was 2024 1.11 . It decreases by 6.42% higher compared to the previous year.

The NatureCell Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.23 KRW
Jan 1, 2019
1.14 KRW
Jan 1, 2020
1.37 KRW
Jan 1, 2021
1.14 KRW
Jan 1, 2022
1.64 KRW
Jan 1, 2023
1.11 KRW
Jan 1, 2024
1.11 KRW
Jan 1, 2025
1.19 KRW
The NatureCell Co Financial Leverage history
YEARFinancial LeverageYoY
1.19+6.42%
1.11+0.04%
1.11-32.30%
1.64+43.70%
1.14-16.32%
1.37+20.31%
1.14-7.26%
1.23-5.90%
1.30-15.84%
1.55+6.72%
1.45-18.71%
1.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NatureCell Co Stock analysis

What does NatureCell Co do? NatureCell Co Ltd generates revenue through three business segments. The Stem Cell Business segment develops stem cell therapeutics, manufactures stem cell culture media, sells stem cell culture cosmetics, and provides blood cell storage services. The Food Business segment produces and sells fruit beverages like tomato juice and peach juice, canned beverages such as sikhye, fruit concentrates, and health functional foods. The Hygiene Business segment manufactures and sells health hygiene products including masks, disinfectants, and wipes. These segments target consumers seeking medical solutions, healthy beverages, and personal care items. The Stem Cell Business segment serves customers interested in advanced medical treatments and skincare, while the Food Business segment caters to consumers looking for natural beverage and health food options. The Hygiene Business segment appeals to individuals prioritizing health and safety through products like masks and disinfectants. All segments focus on delivering quality products under NatureCell's brand name. NatureCell's product portfolio spans therapeutic, beverage, and hygiene categories, with each segment operating independently yet contributing to the company's overall revenue. The Stem Cell Business segment's offerings include culture media and cosmetics, the Food Business segment's products are fruit-based beverages and functional foods, and the Hygiene Business segment provides essential health care items. These diverse segments ensure a steady income stream across multiple consumer needs. NatureCell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NatureCell Co stock

Financial Leverage (Equity Multiplier) of NatureCell Co is 1.19 in 2025.

Financial Leverage (Equity Multiplier) of NatureCell Co changed from 1.11 to 1.19, representing a 6.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) NatureCell Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s NatureCell Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NatureCell Co

All Key Metrics — NatureCell Co